"Look at everything—every time" is a mantra many of us have humming in the background as we go through our clinical day. Accordingly, providing screening examinations for high-risk medications, such as hydroxychloroquine, is a natural service for our profession. Aralen contraindications What is the difference between chloroquine and chloroquine phosphate Plaquenil risks BACKGROUND The American Academy of Ophthalmology recommendations for screening of chloroquine CQ and hydroxychloroquine HCQ retinopathy were published in 2002, but improved screening tools and new knowledge about the prevalence of toxicity have appeared in the ensuing years. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy 2016 95 Revision. Ophthalmology. 2016. 96 6. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of 97 hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. 98 Arthritis Rheum. 1997;4081482-6. 99 7. The scope of the guidelines is limited to management of diabetic retinopathy with special focus on sight threatening retinopathy. It offers guidance regarding service set up to facilitate delivery of optimal clinical care for patients with retinopathy. The guidelines are prepared primarily for ophthalmologists. The retinopathy is hallmarked by parafoveal changes within the retina. Hydroxychloroquine is an analogue to the much older drug chloroquine. Hydroxychloroquine is most frequently used for the management of lupus and rheumatoid arthritis; however, it is now being applied to treatments in adjunctive cancer therapy, diabetes, and heart disease. Hydroxychloroquine retinopathy screening guidelines How to Succeed in Plaquenil Screenings, AMERICAN COLLEGE OF RHEUMATOLOGY Icd 9 code for long term use of plaquenil Research confirms that hydroxychloroquine is safer than chloroquine and that at a daily dose of hydroxychloroquine 6.5mg/kg the risk of retinopathy is negligible if patients are younger than 60 years with normal renal and liver function. 2 In these circumstances regular screening is unnecessary, although we suggest recording visual acuity. Screening for hydroxychloroquine retinopathy Screening.. Clinical Guidelines - The Royal College of Ophthalmologists. Hydroxychloroquine toxicity - EyeWiki. Most screening guidelines recommend screening for HCQ/CQ retinopathy after 5 years of drug therapy Table 2 with annual screening. Baseline evaluation, in some form, is widely recommended to. RCOphth guideline Hydroxychloroquine and Chloroquine Retinopathy NEW screening recommendations February 2018 2 March 2018. The new guideline on screening for hydroxychloroquine and chloroquine retinopathy is written in response to evidence from the United States that shows that hydroxychloroquine retinopathy is more common than previously recognised. Given the initial low risk of HCQ or CQ retinopathy, with a proper dose and in the absence of major risk factors, annual screening can be deferred until there has been 5 years of exposure. Screening should begin sooner if the risk is high Table 1.